Reform

f9a57bfe-51c7-11e9-8939-5623721d3707

Europe’s pragmatic approach to clinical evidence for legacy devices – or why the devil is always in the detail…

By Arthur Brandwood | 30 March 2019
Regulatory affairs demand attention to detail. So when the European Medical Devices Coordination Group released document MDCG 2019-3 - Interpretation of Article 54(2)b we regulatory geeks just knew we should...
shutterstock_708015040

NZ Makes it Formal – Medical Devices Reform in The Land of the Long White Cloud

By Arthur Brandwood | 28 March 2019
New Zealand has always been a relaxed sort of place – and that included the regulation of medical devices which up till now has been limited to a simple notification...
Sauce

China update – regulation with a European sauce?

By Arthur Brandwood | 7 August 2018
CFDA continues to propose more changes to medical device regulation, and as ever the agency looks to international practices and seeks to weave them in to China requirements. A recent...

Search

Recent Posts

Gas Pathways – ISO 18562 progress

Aug 20, 2021

When is a Standard Actually a Standard?

Jul 26, 2021

The bio pharmacy: market authorisations for protein-based medicines

Jul 12, 2021

Update on Notified Bodies designation under MDR / IVDR

Jul 2, 2021

MR Compatibility and Materials Science

Jul 1, 2021

Australia’s TGA releases updated Essential Principles Checklist

May 27, 2021

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE China clinical evidence clinical trials Conformity Assessment coronavirus COVID-19 COVID19 Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines MHRA NMPA Notified Bodies Pharmaceutical PMA postmarket Reform Registrations regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA